Brief: EMA Says CHMP Adopted Positive Opinion Recommending Change On Marketing Authorisation For Abecma

2Seventy Bio

26/01/2024 12:09

Jan 26 (Reuters) - EMA:
    * ADOPTED POSITIVE OPINION RECOMMENDING CHANGE TO TERMS OF
MARKETING AUTHORISATION FOR MEDICINAL PRODUCT ABECMA
    * CHMP ADOPTED EXTENSION TO INCLUDE TREATMENT OF ADULT
PATIENTS
WITH RELAPSED, REFRACTORY MULTIPLE MYELOMA WHO HAVE GOT AT LEAST
2 PRIOR THERAPIES

Source text for Eikon:  ID: 
Further company coverage:  BMY.N 

 ((Reuters.Briefs@thomsonreuters.com;))